These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1938 related articles for article (PubMed ID: 32319693)

  • 1. Epidemiology of Hepatocellular Carcinoma.
    McGlynn KA; Petrick JL; El-Serag HB
    Hepatology; 2021 Jan; 73 Suppl 1(Suppl 1):4-13. PubMed ID: 32319693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and etiological variations in hepatocellular carcinoma.
    Sagnelli E; Macera M; Russo A; Coppola N; Sagnelli C
    Infection; 2020 Feb; 48(1):7-17. PubMed ID: 31347138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology and prevention of hepatocellular carcinoma.
    Monto A; Wright TL
    Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
    Fattovich G; Stroffolini T; Zagni I; Donato F
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing epidemiology of hepatocellular carcinoma in Asia.
    Goh GB; Chang PE; Tan CK
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):919-28. PubMed ID: 26651253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing epidemiology of hepatocellular carcinoma in Asia.
    Zhang CH; Cheng Y; Zhang S; Fan J; Gao Q
    Liver Int; 2022 Aug; 42(9):2029-2041. PubMed ID: 35319165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.
    Chuang SC; La Vecchia C; Boffetta P
    Cancer Lett; 2009 Dec; 286(1):9-14. PubMed ID: 19091458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma.
    Lee SS; Jeong SH; Byoun YS; Chung SM; Seong MH; Sohn HR; Min BY; Jang ES; Kim JW; Park GJ; Lee YJ; Lee KH; Ahn S
    BMC Cancer; 2013 Jul; 13():335. PubMed ID: 23829392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and natural history of hepatocellular carcinoma.
    McGlynn KA; London WT
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population attributable fractions of risk factors for hepatocellular carcinoma in the United States.
    Makarova-Rusher OV; Altekruse SF; McNeel TS; Ulahannan S; Duffy AG; Graubard BI; Greten TF; McGlynn KA
    Cancer; 2016 Jun; 122(11):1757-65. PubMed ID: 26998818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of digestive tract cancers in India. III. Liver.
    Dhir V; Mohandas KM
    Indian J Gastroenterol; 1998; 17(3):100-3. PubMed ID: 9695391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.
    Than NN; Ghazanfar A; Hodson J; Tehami N; Coldham C; Mergental H; Manas D; Shah T; Newsome PN; Reeves H; Shetty S
    QJM; 2017 Feb; 110(2):73-81. PubMed ID: 27634970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease.
    Zhao H; Zhu P; Han T; Ye Q; Xu C; Wu L; Liu F; Yin W; Li Z; Guo Y
    J Clin Lab Anal; 2020 Feb; 34(2):e23075. PubMed ID: 31659795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.
    Tagger A; Donato F; Ribero ML; Chiesa R; Portera G; Gelatti U; Albertini A; Fasola M; Boffetta P; Nardi G
    Int J Cancer; 1999 May; 81(5):695-9. PubMed ID: 10328218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.
    Chan AW; Wong GL; Chan HY; Tong JH; Yu YH; Choi PC; Chan HL; To KF; Wong VW
    J Gastroenterol Hepatol; 2017 Mar; 32(3):667-676. PubMed ID: 27547913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of hepatocellular carcinoma--current status and perspectives.
    Gao J; Xie L; Yang WS; Zhang W; Gao S; Wang J; Xiang YB
    Asian Pac J Cancer Prev; 2012; 13(3):743-52. PubMed ID: 22631642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
    Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
    Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiological and molecular profile of hepatocellular cancer from India.
    Asim M; Sarma MP; Kar P
    Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
    Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
    J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 97.